Key Takeaways
- Chinese dumping relief drove margin recovery: EBITDA margin rebounded to 6.8% in Q4 from 3.6% as Chinese anti-involution measures since February reduced aggressive dumping, improving domestic realizations by 8-10%.
- Revenue still under pressure, but worst believed over: Revenue declined 3% YoY, with FY26 volumes at 44,000 tonnes versus a 63,000-tonne peak in FY24, though management sees the paint sector recovering and believes the company has bottomed out.
- Export pivot underway with US re-entry: Commercial exports to the US resumed two months ago, isostearic acid marketing restarted after a duty-related hold, and management targets exports rising from 8-9% to 20% of sales in FY27.
- New product plant is the medium-term story: A plant using a novel oleochemical process, a first in India, will commission by end-Q2 FY27, with management targeting ₹800-1,000 crore revenue from 40,000 tonnes capacity within five years.
- What to watch next quarter: Whether the paint sector recovery sustains and translates to volume growth, the pace of export ramp-up toward the 20% target, and any signal on Chinese dumping behavior as domestic prices have bounced back.
Chinese Dumping & Realization Recovery
- Dumping scale was material: Chinese producers were dumping 800-1,000 tonnes of dimer per month into the domestic market, equal to Fairchem's entire domestic sales volume, making it unviable to produce and sell at full capacity.
- Relief trigger: Since February end, Chinese government export incentives as high as 15% were removed in many cases, and management believes Chinese companies were likely making losses, so the dumping has moderated.
- Realization impact: Major product realizations improved approximately 8% to 10% because Chinese dumping is no longer happening, directly supporting the Q4 margin recovery.
- Capacity utilization now viable: The company had been deliberately producing and selling less because Chinese competition made it uneconomical; with dumping reduced, selling is viable again and management targets 75-80% utilization in FY27.
- Restart risk acknowledged: Management conceded the Chinese government could reintroduce the 15% incentive, but argued that after two years of loss-making dumping, and given the current geopolitical situation, a return is unlikely.
Jariwala: "Maybe the sense would have prevailed that it does not make any sense to lose money. Absolutely. I mean, that is all possibility. I mean, Chinese government can reintroduce that 15% incentive. I mean, that is not in our hand. But I mean, I do not think so. I mean, for two years they played that game. I do not think they will be able to do more. And that also during this current geopolitical situation."
Margin Trajectory & Cost Levers
- Q4 margin walk: EBITDA margin improved to 6.84% from 3.64%, driven primarily by better price realization as pressure from lower-price Chinese imports moderated.
- Energy cost reduction: Power and fuel costs declined to ₹6 crores in Q4 from ₹8 crores, the result of a completed energy audit and investments in electrical equipment, pumps, motors and heat exchangers; a second energy audit is underway and further reduction is expected.
- Operating leverage ahead: Management expects margins to creep up as capacity utilization increases, with a target of reaching 8% operating margin, which it is fairly confident of achieving.
- Double-digit path conditional: Margins can enter double digits if volume growth continues, rupee devaluation happens, and energy saving initiatives work, though no timeline was committed.
- Long-term aspiration: Management's "dream" is to get back to the 12-15% margin range, but this is aspirational with no attached timeline.
Export Ramp-Up & US Re-entry
- US exports resumed: Commercial exports to the US started two months ago, though currently on a small scale, with the US, Europe and Japan as focused geographies.
- Isostearic acid marketing restarted: Previously on hold due to a 50% duty issue, marketing has now resumed and customers have started asking for samples; meaningful ramp-up is expected in FY27-28.
- Export target: Management expects exports to rise from the current 8-9% of sales to around 20% in FY27 itself, with meaningful export volumes expected within a maximum of six months.
- Eventual 50% target: The longer-term 50% export share target is contingent on new capacity: the current 80,000 tonnes plus a planned 40,000 tonnes, with the major contribution coming from new capacity.
- Rupee depreciation tailwind: Rupee devaluation helps exports because export realization gains are much higher than the associated raw material and energy cost increases, though management declined to quantify the per-1% impact.
New Product & Capacity Expansion
- New product plant: A plant based on a novel oleochemical process, being done for the first time in India, will be commissioned by end of Q2 FY27.
- Revenue potential: Management targets 40,000 tonnes of capacity utilization within five years, which at current price assumptions could yield ₹800-1,000 crores in revenue.
- Margin profile: Margins for the new product are expected to be "much better" than the traditional portfolio and look "fairly robust" at this stage, though no specific numbers were shared.
- Validation timeline: Revenue contribution will take a minimum of two to two and a half years to begin due to the customer validation and approval process; management expects to penetrate the market gradually over five years.
- Bypass fat plant: A separate bypass fat plant will be put into operation next month, with revenue contribution expected to start from Q3 onwards slowly.
- Vitamin E plant idle: The tocopherols/Vitamin E plant is not being utilized currently because the Vitamin E market is not doing well; it will restart once demand picks up.
Jariwala: "It is a newer raw material. Obviously, part of the oleochemical stream. We will be following a novel process. And we will be doing it for the first time in India."
Demand Environment & Volume Recovery
- Paint sector turning: The paint industry, a key end-market that had been navigating structural adjustments, started recovering in March and a robust recovery is underway in the current quarter.
- Linoleic realizations: Realizations for linoleic acid are improving a little bit, adding to the broader realization recovery story.
- Volume context: FY26 volumes fell to 44,000 tonnes from 54,000 in FY25 and a peak of 63,000 in FY24, though the FY24 volume peak did not translate to revenue because prices had fallen sharply.
- FY27 volume expectation: Management expects to reach around 80% capacity utilization of the 80,000-tonne capacity, and is confident the plant will work at more than 95% utilization within two years.
- Past two years characterized as "washed out": Major raw material price changes, with duties swinging from 5.5% to as high as 27.5%, combined with Chinese dumping on finished products, made the last two years exceptionally difficult and discouraged aggressive debt-funded expansion.
Jariwala: "Yes, basically if you really see our last two years have been bad years because of major changes happening in the raw material prices whereby the duties went up from 5.5% to as high as 27.5% on our raw materials and dumping happening on our finished products from China."
Capital Allocation & Balance Sheet
- Buyback completed: The company successfully completed a buyback of 4.25 lakh shares during Q4, increasing promoter holding from 61.2% to 63.2%.
- No major CAPEX in FY27: No CAPEX is planned for FY27 except for energy savings projects, and even those only if the payback is less than four years; the current business does not require any CAPEX.
- FY28 CAPEX contingent: Investment in FY28 depends entirely on whether the new product picks up; if it does, the company will invest, otherwise not.
- Working capital: Expected to remain at around 100-120 days; if volumes increase, the denominator effect may improve it slightly from the current 120 days.
- Focus on top line: Management stated it is now simply focused on improving the top line after the difficult period.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Capacity utilization | Reach ~80% of 80,000-tonne capacity (~64,000 tonnes) | FY27 |
| Capacity utilization | Plant to work at more than 95% | Within two years |
| Export share | Rise from 8-9% to ~20% of sales | FY27 |
| Meaningful export volumes | Achieved | Within ~6 months |
| Operating margin | Reach 8% | This financial year (FY27) |
| New product plant | Commissioned | End of Q2 FY27 |
| Bypass fat plant | Operational, revenue contribution begins | Next month; Q3 onwards |
| New product revenue | First contribution begins | After two to two and a half years (validation) |
| New product capacity utilization | Reach 40,000 tonnes | Within five years |
| New product revenue | ₹800-1,000 crores | At 40,000-tonne utilization |
| Isostearic acid meaningful ramp-up | Achieved | FY27-28 |
| Energy cost | Further reduction | Ongoing (second audit underway) |
| CAPEX (FY27) | None except energy savings with <4-year payback | FY27 |
| CAPEX (FY28) | Only if new product picks up | FY28 |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Revenue from operations | ₹117 cr, 3.2% YoY decline |
| EBITDA | ₹8 cr, margin of 6.9% |
| Adjusted net profit after tax | ₹3.7 cr |
| Revenue from operations (FY26) | ₹460 cr, 14.5% YoY decline |
| EBITDA (FY26) | ₹22 cr, margin of 4.7% |
| Net profit after tax (FY26) | ₹6.2 cr |
| Total volume sold (FY26) | 44,000 tonnes, vs 54,000 tonnes in FY25 |
| Volume sold (Q4) | 10,500 tonnes |
| Domestic sales share | 91% of total revenue |
| Exports share | 8% to 9% of total revenue, expected to reach around 20% |
| Capacity utilization | 65% to 66%, targeting 75% to 80% in FY27 |
| Dimer acid contribution (FY26) | ~₹140 cr, 25% to 30% of turnover |
| Linoleic acid contribution (FY26) | ~30% of turnover |
| Isosteric acid contribution (FY26) | ₹26 cr, 5% to 6% of turnover |
| Realization improvement | 8% to 10% due to reduced Chinese dumping |
| Dividend per share | ₹1, down from ₹7.5 in FY25 |
| Promoter holding | 63.2%, up from 61.2% after buy-back of 4.25 lakh shares |
| Working capital cycle | 100 to 120 days expected |
| New product initial capacity | 8,000 tonnes, first phase capex of ₹20 cr to ₹25 cr |
| New product long-term revenue potential | ₹800 to 1,000 cr at 40,000 tonnes capacity, over five years |